Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men

Vaccine

Volumn 28, Issue 29, 2010, Pages 4638-4643

  Li, Qingchun ^a   Luo, Fengji ^b   Zhou, Zhenhai ^a   Li, Shuming ^b   Liu, Yingjie ^b   Li, Dongliang ^b   Shi, Wei ^b   Raymond, H F ^c   Ruan, Yuhua ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Chinese MSM; HIV vaccine; Willingness to participate

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEAR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PATIENT ATTITUDE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROTECTION; SOCIAL ISOLATION; SOCIAL SUPPORT;

ADOLESCENT; ADULT; AIDS VACCINES; CHINA; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; QUESTIONNAIRES; YOUNG ADULT;

EID: 77953129434     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.073     Document Type: Article

References (29)

1. UNAIDS and WHO. AIDS epidemic update 2009 (2009). http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf Available from: http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf [cited: December 29, 2009]
2. Phase-I clinical trial of self-developed HIV vaccine has been gotten along successfully in China (2008). http://www.99aids.com/info/1950-1.htm Available from: http://www.99aids.com/info/1950-1.htm [cited: November 6, 2008]
3. Phase-II clinical trial of self-developed HIV vaccine was started in China (2008). http://www.chinaaids.cn/n16/n1193/n4073/187745.html Available from: http://www.chinaaids.cn/n16/n1193/n4073/187745.html [cited: November 7, 2008]
4. New development in the field of China AIDS research-HIV vaccine trial on phase I would be conducted next year (2008). http://www.ahinfo.gov.cn/docs09/xinwen/kjwz/kj/kj0312/kj12022.htm Available from: http://www.ahinfo.gov.cn/docs09/xinwen/kjwz/kj/kj0312/kj12022.htm [cited: November 7, 2008].
5. State Council AIDS Working Committee Office, and UN theme Group on HIV/AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China (2007). http://www.chinaids.org.cn/n443289/n443292/6438.html Available from: http://www.chinaids.org.cn/n443289/n443292/6438.html [cited: November 10, 2008]
6. Tian L.G., Ma Z.E., Ruan Y.H., Cao X.Y., Huang J.P., Wang D.R., et al. Incidence rates of human immunodeficiency virus and syphilis as well as the rate of retention in a 6-month follow-up study of female sex workers in areas with heavy drug use in Xichang of Sichuan province, China. Zhong hua Liu Xing Bing Xue Za Zhi 27 11 (2006) 939-942
7. Ruan Y.H., Jia Y.J., Zhang X.X., Liang H.Y., Li Q.C., Yang Y., et al. Incidence of HIV-1, syphilis, Hepatitis B and Hepatitis C virus infections and predicators associated with retention in a 12-month follow-up study among men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr 52 5 (2009) 604-610
8. Li S.W., Zhang X.Y., Li X.X., Wang M.J., Li D.L., Ruan Y.H., et al. Detection of recent HIV-1 infections among men who have sex with men in Beijing during 2005-2006. Chin Med J (Engl) 121 12 (2008) 1105-1108
9. Zhang X.X., Li S.W., Li X.X., Xu J.Q., Li D.L., Ruan Y.H., et al. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. AIDS 21 Suppl. 8 (2007) S59-S65
10. Zhang X.Y., Huang X.G., Xu J.Q., Li S.W., Jiang S.L., Zhang X.X., et al. HIV-specific T cell immunity across the entire HIV genome in Chinese men who have sex with men. Chin Med J (Engl) 119 23 (2006) 1958-1965
11. Feng L., Ding X., Lu R., Liu J., Sy A., Ouyang L., et al. High HIV prevalence detected in 2006 and 2007 among men who have sex with men in China's largest municipality: an alarming epidemic in Chongqing, China. J Acquir Immune Defic Syndr 52 1 (2009) 79-85
12. Ruan S., Yang H., Zhu Y., Wang M., Ma Y., Zhao J., et al. Rising HIV prevalence among married and unmarried among men who have sex with men: Jinan, China. AIDS Behav 13 4 (2009) 671-676
13. Guo H., Wei J.F., Yang H., Huan X., Tsui S.K., and Zhang C. Rapidly increasing prevalence of HIV and syphilis and HIV-1 subtype characterization among men who have sex with men in Jiangsu, China. Sex Transm Dis 36 2 (2009) 120-125
14. Ruan Y., Luo F., Jia Y., Li X., Li Q., Liang H., et al. Risk factors for syphilis and prevalence of HIV, Hepatitis B and C among men who have sex with men in Beijing, China: implications for HIV prevention. AIDS Behav 13 4 (2009) 663-670
15. Yin L., Zhang Y., Qian H.Z., Rui B., Zhang L., Zhu J., et al. Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine 26 6 (2008) 762-768
16. Van de Ven P., Mao L., Crawford J., Prestage G., Grulich A., Kaldor J., et al. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. Int J STD AIDS 16 4 (2005) 314-317
17. de Souza C.T., Lowndes C.M., Szwarcwald C.L., Sutmǒller F., and Bastos F.I. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil. AIDS Care 15 4 (2003) 539-548
18. Dhalla S., Woods R., Strathdee S.A., Patrick D.M., and Hogg R.S. HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. AIDS Care 19 9 (2007) 1118-1127
19. Koblin B.A., Holte S., Lenderking B., and Heagerty P. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. J Acquir Immune Defic Syndr 24 5 (2000) 451-457
20. Buchbinder S., Metch B., Holte S., Scheer S., Coletti A., and Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial. J Acquir Immune Defic Syndr 36 (2004) 604-612
21. Suhadev M., Nyamathi A.M., Swaminathan S., Suresh A., and Venkatesan P. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retroviruses 25 2 (2009) 217-224
22. Ruzagira E., Wandiembe S., Bufumbo L., Levin J., Price M.A., Grosskurth H., et al. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health 14 2 (2009) 196-203
23. Etcheverry M.F., de Lazzari E., Fuchs J.D., Merono M., Sierra E., Romero J.D., et al. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain. AIDS Behav (2008) 10.1007/s10461-008-9486-x
24. Jaspan H.B., Berwick J.R., Myer L., Mathews C., Fisher A.J., Wood R., et al. Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. J Adolesc Health 39 5 (2006) 642-648
25. Newman P.A., Duan N., Lee S.-J., Rudy E.T., Seiden D.A., Kakinami L., et al. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine 24 (2006) 2094-2101
26. Newman P.A., Lee S.-J., Duan N., Rudy E.T., Nakazono T.K., Boscardin J., et al. Preventive HIV vaccine acceptability and risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). Health Serv Res 44 (2009) 2167-2179
27. Newman P.A., Roungprakhon S., Tepjan S., and Yim S. Preventive HIV vaccine acceptability and behavioural risk compensation among high risk men who have sex with men and transgenders in Thailand. Vaccine 28 (2010) 958-964
28. Golub E.T., Purvis L.A., Sapun M., Safaeian M., Beyrer C., Vlahov D., et al. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS Behav 9 3 (2005) 301-309
29. Strauss R.P., Sengupta S., Kegeles S., Mclellan E., Metzger D., Eyre S., et al. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr 26 1 (2001) 63-71